During the past decade, FHP Health Center-Guam conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 1 clinical trials were completed, i.e. on average, 4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "FHP Health Center-Guam" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "Wake Forest University Health Sciences" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "FHP Health Center-Guam" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "FHP Health Center-Guam" are "Breast Carcinoma" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Lung Adenocarcinoma" (2 trials), "Lung Non-Small Cell Carcinoma" (2 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials). Many other conditions were trialed in "FHP Health Center-Guam" in a lesser frequency.

Most popular intervention types in "FHP Health Center-Guam" are "Other" (18 trials), "Drug" (15 trials), "Biological" (9 trials), "Procedure" (8 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Questionnaire Administration" (8 trials), "Quality-of-Life Assessment" (7 trials), "Biospecimen Collection" (5 trials), "Pembrolizumab" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "FHP Health Center-Guam" are 21 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "FHP Health Center-Guam". undefined are not yet recruiting, 13 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in FHP Health Center-Guam, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in FHP Health Center-Guam, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".